Detailed price information for Plus Therapeutics Inc (PSTV-Q) from The Globe and Mail including charting and trades.

Central nervous system tuberculosis encompasses a spectrum of intracranial and intraspinal infections caused by Mycobacterium tuberculosis, most commonly presenting as tuberculous meningitis, ...

A hidden waste-removal pathway in the brain has finally been caught in action. Using cutting-edge MRI scans, researchers discovered that fluid flows along the middle meningeal artery in a slow, ...

Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The University of Texas MD Anderson Cancer Center have found a combination of targeted ...

Wealth Enhancement has acquired a six-advisor team that is parting ways with registered investment advisor TFB Advisors in Overland Park, Kan. The team leaving TFB Advisors had managed about $1.2 ...

Researchers sought to assess the relationship between high-field 7T MRI outcomes and cerebrospinal fluid proteomics to explore the biological pathways underlying MS progression. Cerebrospinal fluid ...

Wealth Enhancement features live advisors who work one on one with clients to create and manage an investment strategy custom fit to their goals. However, the lack of automated and robo advising ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Lucas is a writer and narrative designer from Argentina with over 15 years of experience writing for games and news. He keeps a watchful eye at the gaming world and loves to write about the hottest ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Sarcoidosis is complicated by neurosarcoidosis in 5–15% of cases. Neurosarcoidosis is characterized by ...

Leptomeningeal metastasis (LM) from lung cancer carries an extremely poor prognosis, with patients often presenting severe intracranial hypertension symptoms such as intractable headache and recurrent ...

Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: The MIRAGE trial. This is an ASCO Meeting Abstract from the 2025 ASCO ...